ARTICLE | Distillery Therapeutics
Therapeutics: α-hemolysin (aHL) Patent application filed; unavailable for licensing
February 12, 2015 8:00 AM UTC
In vitro and mouse studies suggest a mAb against multiple Staphylococcus aureus hemolysin and leukocidin toxins could help treat bacterial infection. A yeast display screen of human antibodies identif...